Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancer.

Authors:
Su X; Jin K; Guo Q; Xu Z; Liu Z and 7 more

Journal:
Br J Cancer

Publication Year: 2024

DOI:
10.1038/s41416-023-02572-9

PMCID:
PMC10912081

PMID:
38212482

Journal Information

Full Title: Br J Cancer

Abbreviation: Br J Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neoplasms

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This study was funded by grants from National Natural Science Foundation of China (82002670, 82103408, 82272786, 82272930, 82373276), China Postdoctoral Science Foundation (BX20230091), Shanghai Municipal Natural Science Foundation (22ZR1413400, 23ZR1440300, 23ZR1411700), Shanghai Sailing Program (21YF1407000), Shanghai Municipal Health Bureau Project (202340127, 202340195,20224Y0232), Fudan University Shanghai Cancer Center for Outstanding Youth Scholars Foundation (YJYQ201802) and Shanghai Anticancer Association EYAS PROJECT (SACA-CY22B02, ZYJH202309). All these study sponsors have no roles in the study design, in the collection, analysis and interpretation of data."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025